Cormorant Asset Management

Cormorant Asset Management is a Boston-based investment manager with investment focus in both public and private market innovative companies in the biotechnology and life sciences marketplace.

Cormorant Asset Management is a Boston-based investment manager with investment focus in both public and private market innovative companies in the biotechnology and life sciences marketplace.

See All Exits Recent Exits

Phone:

Fax:



Boston,
Massachusetts, United States

Cormorant Asset Management - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2018-04-26Innovent BiologicsSeries E$150MAlly Bridge Group, Capital Group Private Markets, Hillhouse Capital Management, Legend Capital, Lilly Asia Ventures, Rock Springs Capital, Taikang Life Insurance Company, and Temasek Holdings
2018-04-25Corvidia TherapeuticsSeries B$60MAndera Partners, Apple Tree Partners, Fresenius Medical Care, HBM Healthcare Investments, MedImmune Ventures, Sofinnova Partners, and Venrock
2018-04-06Constellation PharmaceuticalsSeries D$100MCasdin Capital, Deerfield Management, Fidelity Investments, Hillhouse Capital Management, NS Investment, OrbiMed Advisors, Sirona Capital, SR One, The Column Group, Third Rock Ventures, Topspin Partners, University Of California, and Venrock
2018-04-05Eidos TherapeuticsSeries B$64MAisling Capital, Amzak Capital Management, BridgeBio Pharma, Janus Henderson Global Investors, Perceptive Advisors, RA Capital Management, and Viking Global Investors
2018-04-02CMAB BiopharmaSeries B$34MC-Bridge Capital, CDBI Partners, Hangzhou Tigermed Consulting, and Qianhai Fund of Funds
See all 5 investments